» Articles » PMID: 38756558

V6 Vein-preserving Superior Segmentectomy: A Potentially Preferable Option

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 May 17
PMID 38756558
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The increasing identification of pulmonary nodules has led to a growing emphasis on segmentectomy. Nevertheless, the surgical process for segmentectomy is complex and optimizing segmentectomy is a critical clinical concern. This study aimed to evaluate the safety and short- and long-term efficacy of V6-preserving superior segmentectomy.

Methods: We performed a retrospective analysis of patients who underwent thoracoscopic superior segmentectomy at our hospital between January 2019 and June 2020. Eligible patients were categorized into an V6 vein-preserving segmentectomy (VVPS) group and a Non V6 vein-preserving segmentectomy (NVVPS) group depending on the preservation of V6. Primary outcome measures encompassed the evaluation of surgical safety (surgical margins, 3-year overall survival, and disease-free survival), whereas secondary measures included postoperative complication rates, operative time, estimated intraoperative blood loss, length of hospital stay, and associated costs.

Results: The analysis included a final cohort of 78 patients. In the NVVPS group (n = 43), 95.3 % of patients exceeded the tumor diameter, and no positive surgical margins were observed. The 3-year overall survival (OS) and disease-free survival (DFS) rates for the NVVPS group were 95.3 %, with no significant differences in OS (p = 0.572) and DFS (P = 0.800) compared with the VVPS group. Additionally, the median total hospitalization cost for the NVVPS group was 41,400 RMB (IQR, 38,800-43,400), which was significantly lower than that of the VVPS group, showing statistical significance (P < 0.05). No statistically significant differences were observed in the incidence of postoperative complications and length of stay between the two groups (P > 0.05).

Conclusion: V6-preserving superior segmentectomy is a secure and optimized surgical alternative. Its streamlined procedure facilitates easier adoption in primary healthcare facilities, rendering it a superior choice for superior segmentectomy.

References
1.
Liu X, Zhao Y, Xuan Y, Lan X, Zhao J, Lan X . Three-dimensional printing in the preoperative planning of thoracoscopic pulmonary segmentectomy. Transl Lung Cancer Res. 2020; 8(6):929-937. PMC: 6976356. DOI: 10.21037/tlcr.2019.11.27. View

2.
Bao M, Lang Z, Wang Z, Zhang X, Zhao L . Changes in pulmonary function in lung cancer patients after segmentectomy or lobectomy: a retrospective, non-intervention, observation study. Eur J Cardiothorac Surg. 2023; 64(4). DOI: 10.1093/ejcts/ezad256. View

3.
Tane S, Nishio W, Nishioka Y, Tanaka H, Ogawa H, Kitamura Y . Evaluation of the Residual Lung Function After Thoracoscopic Segmentectomy Compared With Lobectomy. Ann Thorac Surg. 2019; 108(5):1543-1550. DOI: 10.1016/j.athoracsur.2019.05.052. View

4.
Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y . Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial. Lancet Respir Med. 2023; 11(6):540-549. DOI: 10.1016/S2213-2600(23)00041-3. View

5.
Bedat B, Abdelnour-Berchtold E, Perneger T, Licker M, Stefani A, Krull M . Comparison of postoperative complications between segmentectomy and lobectomy by video-assisted thoracic surgery: a multicenter study. J Cardiothorac Surg. 2019; 14(1):189. PMC: 6836384. DOI: 10.1186/s13019-019-1021-9. View